Verified July 2026 · Cited to primary sources
KPV: Evidence Grade D — Animal studies only, unproven in humans.
The honest verdict
KPV is not FDA-approved and is under FDA review (July 23, 2026 PCAC). Human evidence is Grade D — cell and animal anti-inflammatory data only, no human trials.
KPV at a glance
- Class
- Synthetic tripeptide (C-terminal fragment of α-MSH)
- Mechanism
- Anti-inflammatory tripeptide that suppresses NF-κB and pro-inflammatory signaling — studied for gut and skin inflammation.
- Also known as
- Lysine-Proline-Valine, α-MSH C-terminal tripeptide
- Research applications
- Gut/IBD-type inflammation (cell and animal colitis models)
- Skin inflammation
- Forms
- subcutaneous injection, oral capsule, topical
- Legal status
- Under FDA review
- WADA (anti-doping)
- Not prohibited (no performance mechanism)
- Evidence grade
- Grade DAnimal studies only, unproven in humans
How we grade evidence
Every grade is assigned by a fixed A–F rubric — human-trial strength, not hype or affiliate status. Last verified July 6, 2026.
What is KPV?
An anti-inflammatory tripeptide studied for gut and skin inflammation — promising in cells and animals, untested in humans.
Anti-inflammatory tripeptide that suppresses NF-κB and pro-inflammatory signaling — studied for gut and skin inflammation.
How strong is the evidence for KPV?
Grade D: preclinical only (cell and animal colitis models), no published human RCT (rule 5 fired).
Primary sources (2)
Is KPV legal? (Status July 2026)
Regulatory limbo — July 2026 PCAC vote pending.
On the July 2026 PCAC docket
KPVis one of the seven peptides the FDA's Pharmacy Compounding Advisory Committee reviews on July 23–24, 2026. Its legal compounding status could change after that vote. Track the FDA peptide vote →
What is KPV used for?
KPV is marketed for the goals below. See how it ranks against other peptides in each — by evidence, not hype.
What does KPV cost — and how do you access it legally?
Typical cost
UNKNOWN
No verified clinic price anchor in the research; marked UNKNOWN.
No legal supervised access route right now.
KPV has no compliant US route today while its compounding status is under FDA review. Vials sold "for research use only" are a gray-market fig-leaf, not a legal loophole — we don't link them. If you pursue KPV, do it with a licensed clinician, and re-check its legal status first.
Is KPVsafe? Side effects & risks
No human safety data; gray-market only. Not listed as WADA-prohibited (no performance mechanism), but that is not a safety endorsement.
Medical disclaimer: This page is independent editorial information, not medical advice, and Best Peptide For That is not a medical provider. We do not provide dosing. Talk to a licensed clinician before starting, stopping, or changing any peptide or medication. Full medical disclaimer.
FAQ
KPV FAQ
What is KPV used for?
KPV is marketed for gut inflammation (IBD-type symptoms) and skin inflammation based on its anti-inflammatory action in cell and animal models. There are no human efficacy trials, so those uses are unproven — Grade D on our scale.
Is KPV legal?
There is no legal supervised US route today. KPV was removed from 503A Category 2 in April 2026 and is on the July 23, 2026 PCAC docket. Until then it is gray-market only.
Compare KPV with…
Head-to-head evidence-grade matchups people weigh against KPV.
Keep reading
BPC-157
The most-hyped, least-human-proven "healing" peptide — extensive rodent data, zero published human trials.
Grade DTB-500
The other half of the "wolverine stack" — soft-tissue recovery claims, but only animal data for the fragment actually sold.
Grade DEpitalon
A longevity/anti-aging peptide built on small, low-quality Russian studies — claims far outrun the evidence.
The monthly peptide evidence brief.
What the research and the FDA actually say — one short email a month. Unsubscribe anytime.
No spam. We never sell your email. Editorial policy.